Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-13 Sale |
2025-02-14 6:00 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
2,558 | $116.86 | $298,923 | 101,739 (Direct) |
View |
| 2025-02-10 Sale |
2025-02-12 6:41 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
980 | $118.27 | $115,909 | 33,561 (Direct) |
View |
| 2025-01-31 Sale |
2025-02-04 5:31 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
1,283 | $152.87 | $196,136 | 35,118 (Direct) |
View |
| 2024-08-13 Sale |
2024-08-15 5:12 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
14,100 | $150.38 | $2,120,347 | 31,528 (Direct) |
View |
| 2024-07-16 Sale |
2024-07-18 4:45 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
900 | $150.04 | $135,037 | 45,628 (Direct) |
View |
| 2024-05-14 Sale |
2024-05-16 4:40 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
30,000 | $137.95 | $4,138,436 | 76,528 (Direct) |
View |
| 2024-02-13 Sale |
2024-02-15 5:27 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
1,352 | $132.85 | $179,612 | 85,552 (Direct) |
View |
| 2024-02-06 Sale |
2024-02-08 7:12 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
2,260 | $138.73 | $313,530 | 30,314 (Direct) |
View |
| 2024-01-31 Sale |
2024-02-02 7:00 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
1,283 | $140.72 | $180,539 | 28,284 (Direct) |
View |
| 2023-08-21 Sale |
2023-08-23 7:58 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
2,132 | $107.39 | $228,958 | 27,131 (Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 7:16 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
28,588 | $102.61 | $2,933,470 | 25,213 (Direct) |
View |
| 2023-01-31 Sale |
2023-02-02 4:53 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
1,283 | $109.98 | $141,108 | 21,357 (Direct) |
View |
| 2022-02-07 Sale |
2022-02-09 6:51 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
4,290 | $80.53 | $345,486 | 20,204 (Direct) |
View |
| 2021-12-01 Sale |
2021-12-03 5:02 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
1,645 | $82.59 | $135,852 | 16,349 (Direct) |
View |
| 2021-02-08 Sale |
2021-02-09 9:30 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
2,910 | $116.82 | $339,942 | 66,940 (Direct) |
View |
| 2020-12-01 Sale |
2020-12-02 4:12 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
1,645 | $94.66 | $155,721 | 11,494 (Direct) |
View |
| 2020-11-12 Sale |
2020-11-16 6:02 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
2,257 | $90.74 | $204,810 | 10,014 (Direct) |
View |
| 2020-08-05 Sale |
2020-08-07 6:22 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
2,257 | $118.9 | $268,356 | 7,983 (Direct) |
View |
| 2020-05-07 Sale |
2020-05-11 8:17 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
15,000 | $110.21 | $1,653,134 | 50,953 (Direct) |
View |
| 2020-04-28 Sale |
2020-04-30 4:25 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
1,741 | $102.49 | $178,435 | 5,953 (Direct) |
View |
| 2020-04-24 Sale |
2020-04-28 8:32 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
1,934 | $99.52 | $192,467 | 7,694 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-12 Option Award |
2025-02-14 6:00 pm |
N/A 2035-02-12 |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
54,072 | $0 | 101,739 (Direct) |
View |
| 2025-02-13 Exercise |
2025-02-14 6:00 pm |
N/A N/A |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
4,807 | $0 | 101,739 (Direct) |
View |
| 2025-02-08 Exercise |
2025-02-12 6:41 pm |
N/A N/A |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
1,860 | $0 | 33,561 (Direct) |
View |
| 2025-01-31 Exercise |
2025-02-04 5:31 pm |
N/A N/A |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
2,436 | $0 | 35,118 (Direct) |
View |
| 2024-08-13 Exercise |
2024-08-15 5:12 pm |
N/A 2027-12-01 |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
14,100 | $0 | 31,528 (Direct) |
View |
| 2024-08-13 Exercise |
2024-08-15 5:12 pm |
N/A N/A |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
14,100 | $73.6 | 31,528 (Direct) |
View |
| 2024-07-16 Exercise |
2024-07-18 4:45 pm |
N/A 2027-12-01 |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
900 | $0 | 45,628 (Direct) |
View |
| 2024-07-16 Exercise |
2024-07-18 4:45 pm |
N/A N/A |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
900 | $73.6 | 45,628 (Direct) |
View |
| 2024-05-14 Exercise |
2024-05-16 4:40 pm |
N/A 2027-12-01 |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
30,000 | $73.6 | 76,528 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 5:27 pm |
N/A 2034-02-13 |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
54,024 | $0 | 85,552 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 7:04 pm |
N/A 2033-02-13 |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
74,053 | $0 | 74,053 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 7:54 pm |
N/A 2032-01-31 |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
76,107 | $0 | 76,107 (Direct) |
View |
| 2021-02-08 Option Award(A) |
2021-03-26 9:48 pm |
N/A 2031-02-08 |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
49,049 | $0 | 49,049 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-09 9:30 pm |
N/A 2031-02-08 |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
52,071 | $0 | 66,940 (Direct) |
View |
| 2020-05-07 Exercise |
2020-05-11 8:17 pm |
N/A 2027-12-01 |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
15,000 | $73.6 | 50,953 (Direct) |
View |